Treating imatinib resistance in the few in CML-A key step towards cure in all

Francis J. Giles*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)1123-1124
Number of pages2
JournalLeukemia Research
Issue number9
StatePublished - Sep 2010


  • COX-2
  • HDAC
  • Imatinib
  • Nilotinib
  • Resistance

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this